Likewise, TRAIL was found to promote the proliferation in human glioma cells through ERK1/2 phosphorylation and the stabilization of the long form of c-FLIP(L) [348], in cholangiocarcinoma cells via NF-kB [13]. Here, MAPK3 is linked to glioma.